CA Patent

CA2061159A1 — Imidazole and benzimidazole derivatives

Assigned to Individual · Expires 1992-08-27 · 34y expired

What this patent protects

HA543a IMIDAZOLE AND BENZIMIDAZOLE DERIVATIVES Abstract Novel compounds are disclosed having the formula I wherein X, R1, R2, R3, R4 and R5 are as defined herein. These compounds inhibit the action of angiotensin II and are useful, therefore, for example, as antihypertensive agen…

USPTO Abstract

HA543a IMIDAZOLE AND BENZIMIDAZOLE DERIVATIVES Abstract Novel compounds are disclosed having the formula I wherein X, R1, R2, R3, R4 and R5 are as defined herein. These compounds inhibit the action of angiotensin II and are useful, therefore, for example, as antihypertensive agents.

Drugs covered by this patent

Patent Metadata

Patent number
CA2061159A1
Jurisdiction
CA
Classification
—
Expires
1992-08-27
Drug substance claim
No
Drug product claim
No
Assignee
Individual
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.